The glucuronyltransferase B4GAT1 is required for initiation of LARGE-mediated α-dystroglycan functional glycosylation

  1. Tobias Willer
  2. Kei-ichiro Inamori
  3. David Venzke
  4. Corinne Harvey
  5. Greg Morgensen
  6. Yuji Hara
  7. Daniel Beltrán Valero de Bernabé
  8. Liping Yu
  9. Kevin M Wright
  10. Kevin P Campbell  Is a corresponding author
  1. Howard Hughes Medical Institute, University of Iowa, Carver College of Medicine, United States
  2. Tohoku Pharmaceutical University, Japan
  3. Graduate School of Engineering, Kyoto University, Japan
  4. University of Iowa, Carver College of Medicine, United States
  5. Oregon Health and Science University, United States

Abstract

Dystroglycan is a cell membrane receptor that organizes the basement membrane by binding ligands in the extracellular matrix. Proper glycosylation of the α-dystroglycan (α-DG) subunit is essential for these activities, and lack thereof results in neuromuscular disease. Currently, neither the glycan synthesis pathway nor the roles of many known or putative glycosyltransferases that are essential for this process are well understood. Here we show that FKRP, FKTN, TMEM5 and B4GAT1 (formerly known as B3GNT1) localize to the Golgi and contribute to the O-mannosyl post-phosphorylation modification of α-DG. Moreover, we assigned B4GAT1 a function as a xylose β1,4-glucuronyltransferase. Nuclear magnetic resonance studies confirmed that a glucuronic acid β1,4-xylose disaccharide synthesized by B4GAT1 acts as an acceptor primer that can be elongated by LARGE with the ligand-binding heteropolysaccharide. Our findings greatly broaden the understanding of α-DG glycosylation and provide mechanistic insight into why mutations in B4GAT1 disrupt dystroglycan function and cause disease.

Article and author information

Author details

  1. Tobias Willer

    Howard Hughes Medical Institute, University of Iowa, Carver College of Medicine, Iowa City, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Kei-ichiro Inamori

    Tohoku Pharmaceutical University, Komatsushima, Japan
    Competing interests
    The authors declare that no competing interests exist.
  3. David Venzke

    Howard Hughes Medical Institute, University of Iowa, Carver College of Medicine, Iowa City, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Corinne Harvey

    Howard Hughes Medical Institute, University of Iowa, Carver College of Medicine, Iowa City, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Greg Morgensen

    Howard Hughes Medical Institute, University of Iowa, Carver College of Medicine, Iowa City, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Yuji Hara

    Graduate School of Engineering, Kyoto University, Kyoto, Japan
    Competing interests
    The authors declare that no competing interests exist.
  7. Daniel Beltrán Valero de Bernabé

    Howard Hughes Medical Institute, University of Iowa, Carver College of Medicine, Iowa City, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Liping Yu

    University of Iowa, Carver College of Medicine, Iowa City, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Kevin M Wright

    Oregon Health and Science University, Portland, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Kevin P Campbell

    Howard Hughes Medical Institute, University of Iowa, Carver College of Medicine, Iowa City, United States
    For correspondence
    kevin-campbell@uiowa.edu
    Competing interests
    The authors declare that no competing interests exist.

Ethics

Animal experimentation: Animal care, ethical usage and procedures were approved and performed in accordance with the standards set forth by the National Institutes of Health and the Animal Care Use and Review Committee at the University of Iowa (protocol #4081122). At the University of Iowa all mice are socially housed (unless single housing is required) under specific pathogen-free conditions in an AAALAC accredited animal facility. Housing conditions are as specified in the Guide for the Care and Use of Laboratory Animals (NRC). Mice are housed on Thoren brand, HEPA filtered ventilated racks, in solid bottom cages with mixed paper bedding. A standard 12/12-h light/dark cycle was used. Standard rodent chow (or special diet if required) and water is available ad libitum.

Copyright

© 2014, Willer et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,620
    views
  • 399
    downloads
  • 90
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Tobias Willer
  2. Kei-ichiro Inamori
  3. David Venzke
  4. Corinne Harvey
  5. Greg Morgensen
  6. Yuji Hara
  7. Daniel Beltrán Valero de Bernabé
  8. Liping Yu
  9. Kevin M Wright
  10. Kevin P Campbell
(2014)
The glucuronyltransferase B4GAT1 is required for initiation of LARGE-mediated α-dystroglycan functional glycosylation
eLife 3:e03941.
https://doi.org/10.7554/eLife.03941

Share this article

https://doi.org/10.7554/eLife.03941

Further reading

    1. Biochemistry and Chemical Biology
    Shraddha KC, Kenny H Nguyen ... Thomas C Boothby
    Research Article

    The conformational ensemble and function of intrinsically disordered proteins (IDPs) are sensitive to their solution environment. The inherent malleability of disordered proteins, combined with the exposure of their residues, accounts for this sensitivity. One context in which IDPs play important roles that are concomitant with massive changes to the intracellular environment is during desiccation (extreme drying). The ability of organisms to survive desiccation has long been linked to the accumulation of high levels of cosolutes such as trehalose or sucrose as well as the enrichment of IDPs, such as late embryogenesis abundant (LEA) proteins or cytoplasmic abundant heat-soluble (CAHS) proteins. Despite knowing that IDPs play important roles and are co-enriched alongside endogenous, species-specific cosolutes during desiccation, little is known mechanistically about how IDP-cosolute interactions influence desiccation tolerance. Here, we test the notion that the protective function of desiccation-related IDPs is enhanced through conformational changes induced by endogenous cosolutes. We find that desiccation-related IDPs derived from four different organisms spanning two LEA protein families and the CAHS protein family synergize best with endogenous cosolutes during drying to promote desiccation protection. Yet the structural parameters of protective IDPs do not correlate with synergy for either CAHS or LEA proteins. We further demonstrate that for CAHS, but not LEA proteins, synergy is related to self-assembly and the formation of a gel. Our results suggest that functional synergy between IDPs and endogenous cosolutes is a convergent desiccation protection strategy seen among different IDP families and organisms, yet the mechanisms underlying this synergy differ between IDP families.

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Jie Luo, Jeff Ranish
    Tools and Resources

    Dynamic conformational and structural changes in proteins and protein complexes play a central and ubiquitous role in the regulation of protein function, yet it is very challenging to study these changes, especially for large protein complexes, under physiological conditions. Here, we introduce a novel isobaric crosslinker, Qlinker, for studying conformational and structural changes in proteins and protein complexes using quantitative crosslinking mass spectrometry. Qlinkers are small and simple, amine-reactive molecules with an optimal extended distance of ~10 Å, which use MS2 reporter ions for relative quantification of Qlinker-modified peptides derived from different samples. We synthesized the 2-plex Q2linker and showed that the Q2linker can provide quantitative crosslinking data that pinpoints key conformational and structural changes in biosensors, binary and ternary complexes composed of the general transcription factors TBP, TFIIA, and TFIIB, and RNA polymerase II complexes.